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It is today widely accepted that several types of high molecular weight (MW)
neurotransmitters produced by neurons are synthesized at the cell body, selectively
stored within large dense core vesicles (LDCVs) and anterogradely transported to
terminals where they elicit their biological role(s). Among these molecules there are
neuropeptides and neurotrophic factors, the main focus of this perspective article. I
here first provide a brief resume of the state of art on neuronal secretion, with primary
emphasis on the molecular composition and mechanism(s) of filling and release of
LDCVs. Then, I discuss the perspectives and future directions of research in the field
as regarding the synthesis and storage of multiple high MW transmitters in LDCVs
and the possibility that a selective sorting of LDCVs occurs along different neuronal
processes and/or their branches. I also consider the ongoing discussion that diverse
types of neurons may contain LDCVs with different sets of integral proteins or dial in a
different fashion with LDCVs containing the same cargo. In addition, I provide original
data on the size of LDCVs in rat dorsal root ganglion neurons and their central terminals
in the spinal cord after immunogold labeling for calcitonin gene-related peptide (CGRP),
neuropeptide K, substance P, neurokinin A or somatostatin. These data corroborate the
idea that, similarly to endocrine cells, LDCVs undergo a process of maturation which
involves a homotypic fusion followed by a reduction in size and condensation of cargo.
They also give support to the conjecture that release at terminals occurs by cavicapture,
a process of partial fusion of the vesicle with the axolemma, accompanied by depletion
of cargo and diminution of size.
Keywords: coexistence, co-localization, co-storage, large granular vesicles, neuropeptide, neurotransmission,
release, small synaptic vesicles
STATE OF ART ON HIGH MOLECULAR WEIGHT
NEUROTRANSMITTER LOCALIZATION AND FUNCTION
Neuronal Secretion and Types of Secretory Vesicles in Neurons
Differently from other cells, neurons display at least three different types of secretory vesicles,
each showing distinctive features as regarding their secretion and biogenesis. Biosynthetic activity
in neurons is very intense and, for a substantial part, devoted to synthesize and assembly these
vesicles. Such an intensive activity is testified by the abundance of rough endoplasmic reticulum
(RER) and the existence of large Golgi complexes in neuronal perikarya. Secretory vesicles
are produced along the regulated secretory pathway and store soluble proteins, peptides or low
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molecular weight (MW) neurotransmitters. Very recent studies
have demonstrated that they may also contain small ribonucleic
acids (sRNAs), at least in the electric organ of Torpedo
californica and in mouse synapses (Kim et al., 2015; Li
et al., 2015, 2017; Gümürdü et al., 2017). Once assembled,
secretory vesicles are actively transported to specific subcellular
domains for extracellular delivery in response to appropriate
signals. The typical large (75–100 nm) dense core vesicles
(LDCVs) in neurons, which mainly concern this perspective
article, contain proteins and/or peptides (Figures 1A,B). It
may be useful to recall here that LDCVs were originally
defined in non-neuronal cell types, where they can be much
larger than those found in neurons. This likely is important
for understanding the differences between peptide hormone
release and neuropeptide release (see below). Proteinaceous
molecules contained in neuronal LDCVs are synthesized in the
cell body, generally as larger precursors that are commonly
referred to as pre-pro-peptides, packaged into LDCVs to
be transported to processes and, eventually, delivered into
the extracellular space (Merighi, 2017). However, it remains
unclear where, along their long journey from cell body to
terminals, maturation of LDCVs’ neurotransmitter proteins
takes place.
Biochemical studies on undifferentiated PC12 cells, which
are devoid of axons, indicate that the maturation of LDCVs is
accompanied by sorting non-regulated secretory proteins,
including the SNARE proteins, from immature vesicles
through the recruitment of clathrin coats, a process that
is considered essential for the maturation of LDCVs (see
Morvan and Tooze, 2008). In parallel, several observations on
the processing of pre-pro-peptides in hypothalamic neurons
and their neurohypophyseal axon terminals support that a
post-translational cleavage of vasopressin, oxytocin and their
neurophysins occurs during axonal transport (e.g., Gainer et al.,
1977a,b). These latter studies did not take into consideration the
aforementioned modifications of the proteins of the LDCVs’
membrane. However, it was more recently demonstrated that, in
cultured trigeminal ganglion neurons, the calcitonin gene-related
peptide (CGRP) occurs together with three SNAREs and
synaptotagmin in LDCVs and that SNARE proteins (SNAP25,
syntaxin one and the synaptobrevin isoforms) were implicated
in the exocytosis from LDCVs (Meng et al., 2007). Even more
recently, SNAP25, and synaptobrevin isoform 2, as well as
SNAP47, were demonstrated to mediate the axonal release of
brain-derived neurotrophic factor (BDNF) from cortical neurons
(Shimojo et al., 2015). Therefore, it appears that also in bona
fide neurons SNAREs may be constituent of the mature LDCVs,
although it remains to be established whether post-translational
axonal cleavage of pre-pro-neurotransmitter proteins is a general
rule or rather a peculiarity of the hypothalamic neurosecretory
neurons.
In nerve terminals, small (40–50 nm) synaptic vesicles (SSVs)
or small clear core vesicles are definitely more numerous
than LDCVs and store and deliver small neurotransmitters
such as acetylcholine, glutamate (Figures 1A,B), glycine, and
gamma amino butyric acid (GABA). Finally, biogenic amines
are differently packaged in neuronal processes within the central
and peripheral nervous systems (see Hökfelt, 2010). In the
latter, biogenic amines are stored in either small (40–60 nm
diameter) dense core vesicles (SDCVs) or irregularly shaped
LDCVs, depending on the particular population of neurons.
Conversely, brain dopamine vesicles do not fall in any of the
described classes because they are 70 nm in diameter and
clear. At the transmission electron microscope (TEM), SSVs
undergoing anterograde axonal transport appear as tubule-
vesicular structures of 50 nm diameter and variable length
(Tsukita and Ishikawa, 1980). These morphological observations,
together with the results of numerous biochemical studies, led
to the conclusion that SSVs are locally assembled at synapses
and that their protein components are reconstituted as complete
synaptic vesicles in the early endosome compartment (Takamori,
2009). Thus, SSVs are characteristically recycled several times
and locally filled with neurotransmitter at synapses, for reuse
following a series of exocytotic and endocytotic events (Lou,
2018).
Differently from SSVs, LDCVs are depleted after secretion,
whereas SDCVs containing noradrenaline are filled with the
neurotransmitter during axonal transport, a fact that explains the
presence of their characteristic dense core in TEM images (Zhang
et al., 2011).
Assembly, Filling and Release of Neuronal
LDCVs
Integral Proteins of LDCVs
Independently from their cargo, LDCVs express a series of
integral proteins that, biochemically, make them a relatively
homogeneous population of vesicles. Among these are
the chromogranins (Bartolomucci et al., 2011), which are
important regulators of cargo sorting in LDCVs biogenesis,
although very recent work in mouse hippocampal neurons
has demonstrated that they are not indispensable for LDCVs’
exocytosis (Dominguez et al., 2018).
LDCVs’ Cargo
The cargo of LDCVs consists of proteinaceous materials.
For the most, these proteins are of small size and currently
referred to as neuropeptides (Figures 1A,B). In its original
definition, a neuropeptide is a small protein molecule contained
in neurons, composed of up to a hundred amino acids. As
mentioned, neuropeptides are usually produced as large, inactive
precursors, which are then enzymatically cleaved to yield the
biologically active peptides. Commonly, precursors contain
several molecules of the same neuropeptide and/or more or
less structurally related compounds. Storage of neuropeptides
and their precursors in LDCVs was first shown in the 80s
of the last century with TEM, but, in more recent times,
LDCVs were demonstrated to be loaded also with bigger
molecules such as BDNF or the glial-derived neurotropic factor
(GDNF) and their pro-peptides. There are numerous examples
of costorage of multiple peptides within individual LDCVs in
various areas of the central and peripheral nervous systems
(Merighi, 2017).
As LDCVs mature, the pro-peptides herein contained
undergo proteolysis to become active. This maturation process
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FIGURE 1 | Storage of neuropeptides in rat dorsal root ganglion (DRG)
neurons. (A,B) Primary afferent terminals in the spinal cord dorsal horn after
triple immunogold labeling with antibodies against glutamate (5 nm gold
particles), calcitonin gene-related peptide (CGRP; 10 nm gold particles
indicated by the yellow arrows in the insert) and substance P (20 nm gold
particles indicated by the red arrow heads in the insert). For details on
antibodies and labeling methods see Merighi et al. (1991). The two rectangles
in (A) are shown at higher magnifications in the inserts. (C) A particular of an
axon terminal in the rat dorsal horn after slice incubation in 75 mM K+ to
stimulate LDCVs’ exocytosis. Tissue has been processed with the Tannic Acid
Ringer Incubation (TARI)-method (Buma et al., 1984). Fixation with tannic acid
prior to conventional glutaraldehyde + osmium post-fixation powerfully
intensifies the electron density of the substances secreted into the extracellular
space. As the cargo of LDCVs is immediately fixed by tannic acid once there,
it remains in close apposition to the terminal membrane that appears thicker
than after conventional transmission electron microscope (TEM) fixation. Note
that three LDCVs in proximity of the axolemma (arrows) display a very
electrondense matrix, whereas two other vesicles (arrow heads) display some
dissolution of their membranes and are lighter. These images may represent
different stages in the process of cavicapture by which neuropeptides may be
released at terminals (see also Figure 2). (D,E) Diameter (mean ± SD) of
unlabeled, single- and double-labeled LDCVs in the neuronal cell body (D) and
central terminals (E) of rat DRG neurons. Note the increase in size of
double-labeled LDCVs compared to unlabeled or single-labeled LDCVs in
DRGs, likely as a consequence of new cargo addition. Note also that in
terminals unlabeled vesicles are smaller than single- and/or double-labeled
LDCVs, which, instead, display similar sizes. This observation supports the
idea that unlabeled vesicles in terminals may have been depleted of their
cargo after cavicapture. Statistics was performed with the GraphPad Prism
7 software. Normality was assessed using the D’Agostino & Pearson normality
test. Means were compared using the Kruskal-Wallis non-parametric test
followed by Dunn’s multiple comparison. # LDCVs: 346 (cell body), 523
(terminals). ∗∗∗P = 0.0004; ∗∗∗∗P < 0.0001 (two-tailed). Abbreviations:
d = dendrite; LDCVs = large dense core vesicles; SSVs = small clear core
vesicles. Bars: (A,B) = 200 nm; (C) = 100 nm.
usually starts in the trans-Golgi network (TGN) and continues
in the secretory vesicles themselves (Kögel and Gerdes, 2009).
The specific molecular signals that drive the packaging and
aggregation of secreted proteins or their characteristic integral
membrane proteins into LDCVs within the TGN are starting to
be unraveled. Among these, one should recall the WD40 domain
protein EIPR-1 and the endosome-associated recycling protein
(EARP) complex (Topalidou et al., 2016). LDCVs emerge
as immature vesicles from the TGN of the Golgi complex
(Figure 2), and it was recently suggested that the conserved
coiled-coil protein CCCP-1 intervenes in the homotypic fusion of
immature LDCVs during the course of their maturation (Cattin-
Ortolá et al., 2017).
Release of Cargo From LDCVs
Neuronal LDCVs are not fully equivalent to non-neuronal
LDCVs, a point that merits attention in discussing current
knowledge on release of cargo from these two classes of LDCVs.
Studies of endocrine and exocrine cells with 300–1000 nm
LDCVs have often implicated F-actin (and sometimes myosin)
in release, because it apparently takes work to move these large
vesicles and extrude their contents. In contrast, experiments on
synaptic neuropeptide vesicles with cytochalasin and mycalolide
B (an F-actin/dynactin disruptor) showed that F-actin does
not affect LDCV mobilization, anterograde transport, synaptic
capture or evoked synaptic neuropeptide release (Shakiryanova
et al., 2005; Cavolo et al., 2015, 2016).
Mechanisms by which LDCV and SDCVs release their
cargo include exocytosis, kiss and run or cavicapture (Merighi,
2017). Exocytosis is a relatively slow process that requires
complete fusion of the vesicle to the plasma membrane; kiss
and run or cavicapture are faster and need the formation of a
transient fusion pore (TFP) between the LDCV and the plasma
membranes. TFP mechanisms permit a fast transfer of amine
neurotransmitters from the inside of SDCVs to the extracellular
space. Of these mechanisms, neuropeptide kiss and run was
recently demonstrated to occur at nerve terminals in Drosophila
(Wong et al., 2015) and in mammalian DRG neurons (Wang
et al., 2017). It seems also possible that neuropeptides and larger
proteins can escape from LDCVs by cavicapture, during which
an expansion of the TFP triggers a partial release of large-size
neurotransmitters (Figures 1C, 2).
As a rule, individual neurons are capable to produce several
high MW transmitters of proteinaceous nature and store them
in LDCVs. In mammals, ultrastructural demonstration was
provided that e.g., two different neuropeptides and a growth
factor with transmitter functions could be co-stored in individual
LDCVs (Salio et al., 2007, 2014). Thus, there are at least twomain
possibilities depicting the modalities of release of these molecules
(Figure 2). From one side, all co-stored high MW transmitter
could be released together. At opposite, individual molecules
could be liberated singularly or in different combinations.
A further issue of complexity derives from the very peculiar
organization of neurons, which form more or less intricate
arborizations of their processes, the latter, in turn, existing
in at least two functionally different types, i.e., axons and
dendrites.
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 August 2018 | Volume 12 | Article 272
Merighi Neurotransmitters in LDCVs
FIGURE 2 | Schematic representation of the process of assembly, filling and
release of LDCVs as extrapolated from immunogold staining studies on rat
primary sensory neurons in DRGs. For simplicity, only the synthesis of two
neuropeptides/proteins (red and green spheres) is depicted. The sizes of
immature and mature LDCVs containing no cargo (negative after immunogold
labeling), only one of the two molecules (single-labeled) or both molecules
(double-labeled) are represented in accordance with the quantitative data
reported in Figures 1D,E. In the example, immature LDCVs budding from the
trans-golgi network (TGN) contain either one or the other neuropeptide and
undergo a process of homotypic fusion to give rise to a larger LDCV. This
vesicle stores both peptides, but still may be regarded as immature on the
basis of its very large size. It subsequently undergoes a process of
condensation with a reduction in size that is completed once the axon terminal
is reached by anterograde transport. In terminals, LDCVs are smaller and very
likely undergo a process of cavicapture to release their cargo (see also the
insert #1 of Figures 1A,C). This process may, in theory, yield to a selective: (a)
or a non-selective (b) release of the co-stored neuropeptides. Irrespectively of
this possibility, individual LDCVs may endure several cycles of
(Continued)
FIGURE 2 | Continued
cavicapture until they are fully depleted of their cargo. Quantitative analysis
(Figure 1E) demonstrates that empty (unlabeled) LDCVs are smaller than
those containing only one (and thus single-labeled) of the two co-stored
peptides. To make the figure easier, LDCVs are represented without their outer
membrane, which is instead clearly visible in tissues subjected to fixation with
tannic acid (Figure 1C). For the same reason, SSVs are not rendered in the
terminal.
FUTURE DIRECTIONS AND
PERSPECTIVES
Neuropeptides and other proteins that may be synthesized by
neurons are known to be physiologically very important, but
also play a substantial role in many pathological conditions.
However, the biogenesis of LDCVs and the mechanisms
governing their molecular composition still remain to be
unraveled in full (Hummer et al., 2017).There are, in my
opinion, two main lines of research to be pursued in the future
for a better understanding of the significance of costorage of
high MW transmitters in neurons. The first should primarily
investigate the synthesis, storage and maturation of LDCVs, the
second their targeting to neuronal processes with an attention
to possible differences among specific neuronal populations.
Information on both issues is substantially missing, as, at present,
investigations have been, for the most, carried out on simple
organisms such as Caenorhabditis elegans or Aplysia californica
or performed in mammalian secretory cells other than neurons,
such as e.g., the adrenal chromaffin cells. In addition, the
relatively small number of investigations in mammalian neurons
has basically been carried out on isolated primary cells or
cell lines in vitro, with few remarkable exceptions discussed
below.
Synthesis and Storage of Multiple High
MW Transmitters in LDCVs
Localization of immature LDCVs in neurons remains a difficult
task to be performed. It still is unclear which morphological
and/or biochemical differences, if any, exist between LDCVs
at different stages of maturity. Ultrastructurally, it appears that
immature vesicles in chromaffin cells are of heterogeneous
size, but all have a dense core. In rat PC 12 cells, the
dense core of immature secretory granules (80 nm) is
smaller than that of mature granules (114 nm), and on
these observation it was hypothesized that one or more
immature granules fuse together during maturation (Tooze
et al., 1991; Tooze, 1991). Other investigations, again conducted
in cells other than neurons, have shown that maturation of
LDCVs accompanies with condensation of the matrix and, at
least theoretically, a reduction in size that, however, could
be compensated by homotypic fusion of immature vesicles
stemming from the TGN (Kögel and Gerdes, 2009). Studies
in mouse chromaffin cells have shown that the neuronal
adaptor protein 3 (AP-3), a vesicle-coat protein that in neurons
intervenes in transmitter release, is localized to the TGN and
hypothesized that AP-3 is selectively expressed in immature
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LDCVs (Grabner et al., 2006). More recently, a genome
editing study on HID-1 knockout PC12 cells has proposed
that the protein, originally demonstrated to be implicated in
neuropeptide sorting and secretion in Caenorhabditis elegans,
influences the early steps in LDCV biogenesis by controlling
the formation of their dense core at the TGN (Hummer et al.,
2017). Thus vesicle size, expression of neuronal AP-3 and/or
HID-1 could be regarded as markers of immature LDCVs in
endocrine cells, but this remains to be established in full for
neurons.
Pioneering work carried out with the use of multiple
immunogold labeling methods more than 25 years ago led
to establishing that multiple neuropeptides could be co-stored
within individual LDCVs in the cell body and processes of
certain primary sensory neurons (for review see Merighi, 2017).
More recent work has shown that neuropeptide co-storage also
occurs in neurons of the central nervous system (Salio et al.,
2007). As neurons normally appear to be producin g more
than a single neuropeptide/transmitter protein (Merighi, 2017),
it seems highly possible that these proteinaceous molecules
are not selectively packaged into different mature LDCVs,
but rather form a mix in individual vesicles once they are
ready to be transported along axons. I have here analyzed
the size of unlabeled, single-labeled and double-labeled LDCVs
in the cell bodies of rat dorsal root ganglion (DRG) neurons
using different combinations of antibodies against several
sensory neuropeptides (CGRP, the tachykinins neuropeptide
K, substance P and neurokinin A or somatostatin) with
different double immunogold labeling techniques (Merighi
and Polak, 1993). It is of interest that in these neurons
there is no difference in size between unlabeled and single-
labeled LDCVs, whereas double-labeled vesicles are larger
(Figure 1D). This observation is consistent with the idea
that LDCVs containing just one component of the peptide
mix are immature and that the increase in size of mature
double-labeled vesicles is a consequence of homotypic fusion
with other immature LCDVs containing the second peptide
(Figure 2), as shown in endocrine cells (Kögel and Gerdes,
2009). As we have previously demonstrated that mature LDCVs
in the central terminals of the DRG neurons may contain
a mix of three (and likely even more) neuropeptides/larger
proteinaceous transmitters (Salio et al., 2007, 2014), the data
herein reported are strongly indicative of the possibility that
homotypic fusion may be a general phenomenon through which
LDCVs mature before being transported to terminals. Co-stored
proteinaceous transmitters occur in LDCVs in remarkably
constant ratios. We have e.g., demonstrated that substance
P, CGRP and BDNF occur in a stoichiometric ratio of
0.7 BDNF:1 CGRP:1 substance P in neurons of DRGs and central
nucleus of amygdala (Salio et al., 2007). Therefore, it seems
reasonable that such a ratio is attained at the level of protein
synthesis, before individual molecules are directed to the TGN
(Figure 2).
The main functional implication of co-storage of bioactive
molecules within LDCVs is that the neuropeptides and/or the
other high MW transmitter herein contained may be released
together and probably act together in determining the response
of target cells. It would be interesting to investigate whether or
not these co-stored molecules are indeed released in concert,
or if some sort of mechanisms would permit a selective release
according to functional needs. Under this perspective, the
relative rate of individual peptide dissolution from the LDCV
core (matrix) might be important, since it is critical for the
speed of peptide secretion in vitro (for a recent review see
Merighi, 2017). I have very recently discussed the possibility that
two functionally antagonist subpopulations of peptidergic DRG
neurons exchange their information to regulate nociception
(Merighi, 2018). These two populations of neurons contained
a mix of peptides with either BDNF (Merighi et al., 2008)
or GDNF (Salio et al., 2014). It appeared highly probable
that the two neurotrophic factors come into play only in
particular functional conditions, e.g., when the sensory system
was overstimulated under inflammatory conditions. In the
future, it would be interesting to check whether these molecules
can indeed undergo some sort of selective release, as this would
represent an additional regulatory mechanism to finely tune
nociception.
Are LDCVs Selectively Targeted to
Different Neuronal Processes?
Whether or not LDCVs are selectively targeted along different
neuronal processes and/or their branches remains to be
established in full. Our immunogold studies onto the DRG
neurons and their central and peripheral projections were
indicative of a lack of selectivity, as the same combination
of peptides, e.g., substance P and CGRP, is detected at both
peripheral (Gulbenkian et al., 1986) and central (Merighi et al.,
1991) axonal projections. However, we did not investigate this
issue in full, and, to the best of my knowledge, it still stands as an
open question.
At the central projections of the peptidergic DRG neurons
in spinal cord there is a very large fraction (virtually all?)
of the total population of LDCVs containing coexisting
neuropeptides/protein transmitters compared to the very limited
pool of these vesicles in the cell body of these neurons. Another
issue which deserves future investigations is the occurrence
and significance of unlabeled LDCVs at axon terminals. I have
often interpreted this as a false negative observation, as: 1.
There is a general consensus, also based onto light microscopic
and transcriptomics studies, that all DRG peptidergic neurons
contain their main peptide marker CGRP (Amara et al., 1985).
Therefore a lack of CGRP immunoreactivity would be difficult
to explain in these neurons; 2. Antigenicity in post-embedding
immunogold labeling techniques on plastic sections (which are
surface reactions) may often fall below the limits of sensitivity
of these procedures (Merighi et al., 1991). To obtain additional
cues on this issue, here I have calculated the size of LDCVs in the
central terminals of the rat DRG neurons after CGRP+substance
P or CGRP+somatostatin double labeling of the dorsal horn
(Figure 1E). Remarkably, and differently from what is observed
at the cell body (Figure 1D), double- and single-labeled LDCVs
are larger than unlabeled vesicles. These observations give
support to the idea that peptides are indeed released from these
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vesicles through cavicapture (Figure 1C), a process by which
individual LDCVs do not disappear after totally flat themselves
against the neurolemma as in the well know regular exocytosis
of SSVs (Rutter and Tsuboi, 2004)—see also the multi-media
annex inMerighi, 2017. If this interpretation is correct, unlabeled
LDCVs in the central terminals of the DRG neurons could be
regarded as depleted of their cargo and thus not as technical
artifacts (Figure 2). This conclusion, as mentioned above, is
strongly based on the notion that CGRP is expressed in all
peptidergic neurons in DRGs. Therefore, to generalize it to
different (or all) types of LDCV-containing terminals would
require to identify a general peptide marker for each neuronal
population, to exclude that unlabeled LDCVs, in terminals other
that those investigated here, contain a neuropeptide or other
cargo that has simply not been assayed.
It is also of interest that when the mean sizes (±SD) of
unlabeled, single- and double-labeled LDCVs are compared
between the cell body and central terminals of the DRG
neurons, those in perikarya are larger than in terminals for all
the three groups (unlabeled LDCVs: cell body 105.8 ± 31.21,
terminals 68.91 ± 12.8, P < 0.0001; single labeled LDCVs:
cell body 100.3 ± 17.93, terminals 75.13 ± 15.09, P < 0.0001;
double labeled LDCVs: cell body 164.5 ± 43.54, terminals
78.26 ± 15.44, P < 0.0001; Mann-Whitney test; #LDCVs = 878).
This observation is in accordance with data on endocrine cells
where a condensation of LDCVs was demonstrated in parallel
with maturation (Kögel and Gerdes, 2009).
Other Sources of Complexity Still Await to
Be Cleared
It is of interest that chromogranin B and phogrin, another
integral protein of LDCVs in endocrine cells, have been reported
to be specifically contained in LDCVs from excitatory and
inhibitory hippocampal neurons, respectively (Ramírez-Franco
et al., 2016). This observation deserves further investigations as
it opens the yet unforeseen possibility that integral proteins of
LDCVs may be different in diverse types of neurons.
Also, a study on the cellular processing of neuropeptide
Y (NPY) has demonstrated that differential trafficking
of immunoreactive LDCVs occurs in hippocampal vs.
hypothalamic neurons (Ramamoorthy et al., 2011). If these
observations will be extended to other neuropeptides or
proteinaceous cargo of LDCVs, further complexity will be
added, as trafficking of neuropeptide-containing LDCVs could
be specific for different populations of neurons, and perhaps
not determined entirely by the characteristics of the particular
peptide per se.
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